Treatment options for ovarian cancer
/
Up to 85 percent of women experience recurrence of high-grade serous ovarian cancer — the most common subtype of ovarian cancer — after standard treatment with the chemotherapy drug carboplatin.
Read MoreWOMEN'S HEALTH
Ovarian Cancer Deaths on Decline
/
Deaths from ovarian cancer fell worldwide between 2002 and 2012 and are predicted to continue to decline in the USA & European Union.
Read MoreOVARIAN CANCER TREATMENT UNDERUSED: RESEARCH
/
Less than half of women suffering from ovarian cancer who are qualified to get combined chemotherapy treatments only receive it. The study was published in the Journal of Clinical Oncology. It was a collaborative effort of six leading cancer institutes, including The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Read More